Potential therapy for incurable Charcot-Marie-Tooth disease

Researchers discover new treatment approach for this hereditary neurological disorder

2014-08-27

(Press-News.org) This news release is available in German.

Charcot-Marie-Tooth disease type 1A is the most common inherited disease affecting the peripheral nervous system. Researchers from the Department of Neurogenetics at the Max Planck Institute of Experimental Medicine and University Medical Centre Göttingen have discovered that the maturity of Schwann cells is impaired in rats with the disease. These cells enwrap the nerve fibres with an insulating layer known as myelin, which facilitates the rapid transfer of electrical impulses. If Schwann cells cannot mature correctly, an insufficient number of nerve fibres is covered with myelin during development. According to the researchers, the growth factor neuregulin-1 has immense therapeutic potential: rats treated with neuregulin-1 have more myelinated nerve fibres. The symptoms of the disease diminish significantly as a result.

Patients with Charcot-Marie-Tooth disease type 1A harbour an extra copy of the PMP22 gene which leads to the overproduction of the peripheral myelin protein 22 (PMP22), a key component of myelin. This causes slow, progressive nerve damage, which can begin as early as childhood. Patients suffer from numbness, tingling and pains in the arms and legs, as well as weakness of leg and arm muscles. Some patients can only move around with the help of a wheelchair. The disease has been incurable to date, as little is known about the fundamental mechanisms of the disorder.

The researchers in Göttingen have now studied genetically modified rats, which, like Charcot-Marie-Tooth patients, produce too much PMP22. In these animals, the Schwann cells cannot mature properly, with the result that insufficient numbers of axons are enwrapped with myelin during development. "This is caused by an imbalance of two signalling pathways in the Schwann cells – the PI3K/AKT and the MEK/ERK signalling pathway – which are important for cell maturation," explains Robert Fledrich from the Max Planck Institute of Experimental Medicine.

In this latest study, the scientists tested the therapeutic potential of the growth factor neuregulin-1. They were able to show that the balance between the two signalling pathways could be restored by administering neuregulin-1. The growth factor is normally produced by nerve cells and acts as an important maturation signal for Schwann cells during development. In the case of acute nerve damage, it is also formed by Schwann cells and plays an important role in repairing damaged nerves. "In genetically modified rats, even a brief neuregulin-1 treatment within the first two weeks of life improves the animals' disease symptoms until they reach adulthood," says co-author Ruth Stassart.

The scientists and the neurologists from Michael Sereda's Research Group now want to conduct additional studies to drive forward the development of a treatment for Charcot-Marie-Tooth disease type 1A. Applying the findings to patients, however, is still a long way off. A therapy with Neuregulin itself is not safe for patients. Therefore, drugs that can imitate the neuregulin-1 signalling pathway will be tested. The recently established Germany-wide network for Charcot-Marie-Tooth disease (CMT-NET) should help in this regard. Patients, researchers and doctors will be able to use the network in Germany to find out about the progress being made in researching this little-known disease.

INFORMATION:

Original publication
Robert Fledrich, Ruth M. Stassart, Axel Klink, Lennart M. Rasch, Thomas Prukop, Lauren Haag, Dirk Czesnik, Theresa Kungl, Tamer A.M. Abdelaal, Naureen Keric, Christine Stadelmann, Wolfgang Brück, Klaus–Armin Nave and Michael W. Sereda
Soluble neuregulin-1 promotes Schwann cell differentiation in Charcot–Marie–Tooth Disease 1A
Nature Medicine, 24 August 2014 (doi: 10.1038/NM.3664)

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks

2014-08-27

Ebola is a rare, but deadly disease that exists as five strains, none of which have approved therapies. One of the most lethal strains is the Sudan ebolavirus (SUDV). Although not the strain currently devastating West Africa, SUDV has caused widespread illness, even as recently as 2012. In a new study appearing in the journal ACS Chemical Biology, researchers now report a possible therapy that could someday help treat patients infected with SUDV. John Dye, Sachdev Sidhu, Jonathan Lai and colleagues explain that about 50-90 percent of ebola patients die after experiencing ...

How to prevent organic food fraud

2014-08-27

A growing number of consumers are willing to pay a premium for fruits, vegetables and other foods labelled "organic", but whether they're getting what the label claims is another matter. Now scientists studying conventional and organic tomatoes are devising a new way to make sure farms are labelling their produce appropriately. Their report, which appears in ACS' Journal of Agricultural and Food Chemistry, could help prevent organic food fraud. Researchers from the Bavarian Health and Food Safety Authority and the Wuerzburg University note that the demand for organic ...

New study throws into question long-held belief about depression

2014-08-27

New evidence puts into doubt the long-standing belief that a deficiency in serotonin — a chemical messenger in the brain — plays a central role in depression. In the journal ACS Chemical Neuroscience, scientists report that mice lacking the ability to make serotonin in their brains (and thus should have been "depressed" by conventional wisdom) did not show depression-like symptoms. Donald Kuhn and colleagues at the John D. Dingell VA Medical Center and Wayne State University School of Medicine note that depression poses a major public health problem. More than 350 million ...

Fear, safety and the role of sleep in human PTSD

2014-08-27

The effectiveness of post-traumatic stress disorder (PTSD) treatment may hinge significantly upon sleep quality, report researchers at the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System in a paper published today in the Journal of Neuroscience. "I think these findings help us understand why sleep disturbances and nightmares are such important symptoms in PTSD," said Sean P.A. Drummond, PhD, professor of psychiatry and director of the Behavioral Sleep Medicine Program at the VA San Diego Healthcare System. "Our study ...

Men who are uneducated about their prostate cancer have difficulty making good treatment choices

2014-08-27

They say knowledge is power, and a new UCLA study has shown this is definitely the case when it comes to men making the best decisions about how to treat their prostate cancer. UCLA researchers found that men who aren't well educated about their disease have a much more difficult time making treatment decisions, called decisional conflict, a challenge that could negatively impact the quality of their care and their long-term outcomes. The study should serve as a wake-up call for physicians, who can use the findings to target men less likely to know a lot about their ...

In sync and in control?

2014-08-27

In the aftermath of the Aug. 9 shooting of an 18-year-old African American man by a white police officer in Ferguson, Missouri, much of the nation's attention has been focused on how law enforcement's use of military gear might have inflamed tensions. But what if the simple act of marching in unison — as riot police routinely do — increases the likelihood that law enforcement will use excessive force in policing protests? That's the suggestion of a new study by a pair of UCLA social scientists. "We have found that when men are walking in step with other men, they ...

Study identifies upside to financial innovations

2014-08-27

Financial innovations can make or break an economy. While the negative impact of financial innovation has been extensively covered, a new study of financial innovations before and during the last financial crisis indicates that financial innovations are not all bad. Many provide positive returns, especially in the United States. However, those that are easy for consumers to understand provide the best returns for investors. The study by Gerard J. Tellis, professor, director of the Center for Global Innovation and Neely Professor of American Enterprise at USC Marshall ...

Soda tax for adolescents and exercise for children best strategies for reducing obesity

2014-08-27

Ann Arbor, MI, August 27, 2014 — Childhood obesity in the United States remains high. A tax on sugar-sweetened beverages such as sodas, energy drinks, sweet teas, and sports drinks would reduce obesity in adolescents more than other policies, such as exercise or an advertising ban, and would also generate significant revenue for additional obesity prevention activities, say researchers writing in the American Journal of Preventive Medicine. The study also demonstrated that physical activity would benefit children ages 6-12 most. Nearly one in three young people between ...

Happy Camp and July Fire Complexes in California

2014-08-27

As of seven hours ago the Happy Camp Complex of fires had consumed 24,939 acres of land in Northern California, the July complex had consumed 35,530 as of eight hours ago. Lightning strikes started seventeen fires on the Happy Camp Ranger District of the Klamath National Forest when a thunderstorm passed through the area on August 11, 2014. All but three of those fires are now 100 percent contained. The following is a list of contained fires and their size at containment: Delta, 150 acres; Sutcliffe, 27 acres; Jackson, 21 acres;Thompson, 17 acres; Tims, 13 acres; Ranch, ...

Researchers discover why Listeria bacterium is so hard to fight

2014-08-27

Listeria is a dreaded bacterium that can be found in both unprocessed and processed foods. Over the last few weeks, 28 persons in Denmark have been infected with Listeria from processed food, sold in supermarkets. 13 have died. The bacterium is notoriously difficult to fight because it has an almost uncanny ability to adapt to changes in its surroundings, says Associate Professor Birgitte Kallipolitis, University of Southern Denmark. Together with colleagues from the Department of Biochemistry and Molecular Biology, she has published a study, which in details reveals ...

Dr. Megan Abbott and the University of Colorado awarded $450,000 establishing a Clinical Research Center of Excellence that will also serve as a second site for SYNGAP1 ProMMiS

Empire Discovery Institute appoints Dr. Ronald Newbold as Chief Executive Officer

[Press-News.org] Potential therapy for incurable Charcot-Marie-Tooth disease
Researchers discover new treatment approach for this hereditary neurological disorder

Potential therapy for incurable Charcot-Marie-Tooth disease

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: